New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Hanger Inc (NYSE:HGR), VIVUS, Inc. (NASDAQ:VVUS)
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) declined -0.66%, trading on 2.66 million shares, to end the trade at $16.56. If we look at its trading history of the past 52 weeks, the share price suffered a low of $10.43 and was moved to the maximum level of $17.58. The stock changed hands in a range of $16.29 to $16.67, bringing its market capitalization to about $2.96 billion. Allscripts Healthcare Solutions, Inc. (Allscripts) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations. The Company provides a variety of integrated clinical software applications for hospitals, physician practices and post-acute organizations.
Will MDRX Get Buyers Even After The Recent Rally? Find Out Here
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) declined -8.08%, to complete the trading session at $4.78, with a total volume of 2.25 million shares. The stock, on average, trades on a volume of 1.60 million shares. In the past 52 weeks, the share price has not declined below $2.53 and above $7.45. It floated in a range of $4.73 to $5.30 during the last trading session, with a beta value of 1.24. Its market capitalization now moved to about $290.75 million. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers.
Will PGNX Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Hanger Inc (NYSE:HGR) recorded a fall of -13.51% and was in a range of $33.15-$34.11 before closing at $33.81. The share price hit its 52-week low of $27.26 and $40.71 was the best price. The stock completed the day with a total volume of 2.22 million shares, versus an average volume of 155,785 shares. Hanger, Inc., formerly Hanger Orthopedic Group, Inc., is a provider of services and products that enhance human physical capabilities. It provides orthotic and prosthetic patient care services, distribute orthotic and prosthetic devices and components, manage O&P networks, and provide therapeutic solutions to the post acute market. It is an owner and operator of orthotic and prosthetic patient care centers in the United States and a distributor of O&P products in the United States.
Is it the Right to Grab HGR after the Recent Slump? Get Free Trend Analysis Here
VIVUS, Inc. (NASDAQ:VVUS) declined -3.01% yesterday, bringing its market capitalization around $754.65 million. The total number of shares that changed hands during the session was 2.20 million shares, as compared to average trading volume of 1.99 million shares. The share price, after opening at $7.55, made a high of $7.65 and hovered above $7.37 to end the day at $7.42. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity .
Will VVUS Reach the Bottom after Yesterday’s Correction? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)